Target intelligence / Profile preview

Eukaryotic translation initiation factor 2 subunit alpha (eIF2-alpha) (EIF2S1)

Target
EIF2S1
Molecular classification
Enzyme, Other
01

Overview

Eukaryotic translation initiation factor 2 subunit alpha (EIF2S1), also known as eIF2-alpha, is a central regulator of protein synthesis initiation in eukaryotic cells (UniProt: P05198). It functions as part of the eIF2 heterotrimeric complex, which is responsible for delivering the initiator methionyl-tRNA to the 40S ribosomal subunit (PubMed: 16289705). The activity of EIF2S1 is primarily controlled by its phosphorylation at Serine 51 by a family of four kinases (PERK, PKR, GCN2, and HRI) in response to various cellular stresses, such as endoplasmic reticulum stress, viral infection, and nutrient deprivation (PubMed: 19131336). This phosphorylation event triggers the integrated stress response (ISR), which globally suppresses protein synthesis to conserve energy while selectively promoting the translation of stress-adaptive genes like ATF4 (PubMed: 33384352). Dysregulation of the EIF2S1-mediated ISR is implicated in a wide range of pathologies, including cancer, where it supports tumor survival under harsh conditions, and neurodegenerative diseases like Alzheimer's and Parkinson's, where chronic activation leads to neuronal dysfunction (PubMed: 36719671). Therapeutic strategies targeting this pathway include small molecules like Salubrinal and Sephin1, which inhibit the dephosphorylation of EIF2S1 to prolong the protective stress response, and ISRIB, which reverses the inhibitory effects of EIF2S1 phosphorylation to restore normal translation (Wikipedia; BioCentury).

Other names
eIF2-alphaeIF-2-alphaEIF2AEukaryotic translation initiation factor 2 subunit 1eIF-2A
02

Mechanism of action

Inhibition of eIF2-alpha dephosphorylation and modulation of the integrated stress response

03

Biological functions

Signal transductionApoptosisCell proliferationCell deathOther
04

Disease associations

CancerNeurodegenerative diseaseInfectionOther
05

Safety considerations

Systemic toxicity due to global translation inhibitionImpairment of normal cellular stress responses
06

Interacting drugs

Salubrinal

3 more in the full profile.

07

Biomarkers

Phosphorylated eIF2-alpha (p-eIF2α)EIF2S1 protein expression

Beyond the preview

Go deeper on Eukaryotic translation initiation factor 2 subunit alpha (eIF2-alpha) (EIF2S1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic translation initiation factor 2 subunit alpha (eIF2-alpha) (EIF2S1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call